Featured News

Consider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.

The Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.

The Celiac Disease Foundation announces its newest appointee, William Thurston, to its Board of Directors.

The FDA released the long-awaited draft guidance, “Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet."

This year, we are proud to acknowledge the outpouring of support we received during the month of May.  

Digestive Disease Week (DDW), the largest and most important gathering of gastrointestinal researchers in the world, was held in San Diego from May 21-24, 2022.

The month of May is Celiac Disease Awareness Month, and in an effort to bring celiac disease into the public eye, Marilyn G. Geller, Chief Executive Officer of the Celiac…

Anokion SA released successful results from their Phase 1 ACeD clinical trial and they will be moving forward with Phase 2 trials later this year.

We are pleased to announce that CDF Board Member, Kristin Yarema, PhD, was honored as a 2022 Medical Marketing & Media Woman of Distinction.

The Celiac Disease Foundation is pleased to announce the establishment of two international celiac disease research prizes to inspire a new generation of researchers whose work in celiac disease will be invaluable.